On June 2, the National Joint Procurement Office issued the “National Drug Centralized Procurement Document (GY-YD2021-2)” through the Shanghai Sunshine Pharmaceutical Purchasing Network. According to this document, the fifth batch of national drug procurement will be opened in Shanghai on June 23.
On May 8, Shanghai Sunshine Purchasing Network issued the “Notice on the Implementation of the Fifth Batch of Drug Information Collection Work for Centralized Drug Procurement of National Organizations”, stating that since 2021 Starting from May 10, the Joint Procurement Office has launched the fifth batch of national-organized drug centralized procurement related information declaration work. According to the published “Scope of Drug Application”, this centralized procurement involved a total of 60 drugs and 202 product specifications.
According to the latest documents, 58 products are involved in the fifth batch of centralized procurement, which is less than the 60 products announced at the time of reporting of mifepristone and carbet Two varieties of oxytocin.
The fifth batch of national drug collection list: